SCHEMBL20174314

SCHEMBL20174314

c1ccc(-c2cc(-c3cccc4ccccc34)nc(-c3ccc(-c4cccc5c4C4(c6ccccc6-c6ccccc64)c4oc6ccccc6c4-5)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
MAPT P10636 7/20 0.36
KMT2A Q03164 6/20 0.36
HPGD P15428 5/20 0.36
MEN1 O00255 5/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 2/20 0.36
ATM Q13315 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GLA P06280 1/20 0.36
NTSR1 P30989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174315 0.94 ENPP3 (0.35) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL22326574 0.92 ENPP3 (0.34) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174311 0.92 MAPT (0.38) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174317 0.89 ALDH1A1 (0.35) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174372 0.89 ALDH1A1 (0.35) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174352 0.89 ALDH1A1 (0.34) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174356 0.88 KMT2A (0.36) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174324 0.87 MAPT (0.35) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174396 0.87 KMT2A (0.35) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL20174382 0.87 CYP1A1 (0.38) ALDH1A1MAPTKMT2AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG ALDH1A1 33/4885MAPT 811/4885KMT2A 1480/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG ALDH1A1 33/4885MAPT 811/4885KMT2A 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.